And despite recent advances in therapeutic methods, including immunotherapy and receptor tyrosine kinases inhibitors (TKIs), gastric cancer remains one of the most intractable solid tumors characterized by frequent posttreatment relapse and metastasis [37]. Here, NTRK1 is linked to gastric cancer.